| Financial Year |
March 31 2023 |
| Monetary Funds |
188,616,558.59 |
| Held-for-trading Financial Assets |
140,306,999.99 |
| Notes Receivable |
57,714,152.64 |
| Accounts Receivable |
130,126,741.85 |
| Advances to Suppliers |
467,418.59 |
| Other Receivables |
290,013.68 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
72,341,210.12 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,424,941.39 |
| Total Current Assets |
616,594,793.90 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
1,972,332.21 |
| Fixed Assetes |
120,534,179.22 |
| Under-construction Projects |
24,737,068.23 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
41,706,409.58 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,382,127.41 |
| Deferred Income Tax Assets |
2,276,774.93 |
| Other Non-Current Assets |
3,201,470.00 |
| Sub-Total of Non-Current Assets |
196,835,204.64 |
| Total Assets |
813,429,998.54 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
90,305,643.70 |
| Accounts Payable |
14,968,937.34 |
| Accounts Received In Advance |
14,915.46 |
| Employee Compensation Payable |
3,852,698.80 |
| Taxes Payable |
4,821,365.08 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,525,332.44 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
18,671.90 |
| Other Current Liabilities |
21,935,420.68 |
| Sub-Total of Current Liabilities |
139,486,811.27 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,374,666.68 |
| Total Liabilities |
141,861,477.95 |
| Paid-In Capital(Or Share Stock) |
201,226,732.00 |
| Capital Surplus |
187,062,936.09 |
| Surplus Reserve |
35,866,196.60 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
247,412,655.90 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
671,568,520.59 |
| Owner's Equity（Stockholder's Equity） |
671,568,520.59 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
813,429,998.54 |
